Crédit Mutuel Innovation

Investor profile | Builders Republic

Part of Crédit Mutuel Alliance Fédérale (Filiale de gestion)

About

Crédit Mutuel Innovation is the venture capital team of Crédit Mutuel Equity, the private equity subsidiary of Crédit Mutuel Alliance Fédérale. Active since 2003, initially under the name CM-CIC Innovation, it invests the group's own funds without exit constraints: its allocation was doubled to €500M in May 2023, with a pace of about €50M invested per year. It mainly leads or co-leads Series A rounds, less frequently seeds or Series B, with check sizes from €1M to €20M and an average entry ticket of €4M to €5M, in health, deeptech, and digital sectors. Offices in Paris, Lyon, Nantes, and Marseille. The portfolio includes Tissium, whose Series A it co-led in 2013 and followed until 2023, Implicity and Therapixel, Series B co-led in 2022, Planity, Quandela, HarfangLab, Ganymed Robotics, AB Tasty, and Zeliq, whose Series A it co-led in 2026 with The Moon Venture. For a founder seeking a lead for a Series A with patient capital, it's a solid option.

Key facts

Type
Corporate VC
Stages
Seed,Series A,Series B
Sectors
Deeptech, Healthcare, Software/SaaS
Headquarters
France
Offices
Paris, Lyon, Nantes, Marseille
Geographic focus
France
Founded
2003

Track record

  • Portfolio companies: 82
  • Total investments: 94
  • Exits: 27

Notable investments

AB Tasty, Planity, HarfangLab, Obat, Implicity, Quandela, Latitude

Funds by stage

Other funds investing at the same stages, list by list.

Funds by sector

The funds investing in each sector, based on their rounds over the last 36 months.